Pfizer Says CHMP Gives Positive Opinion For Anti-Smoking Pill Champix - Update
Pfizer, Inc. revealed it has received a positive opinion from the Committee for Medical Products for Human Use or CHMP to authorize the marketing of Champix, which is the company’s new drug for the treatment of smoking cessation.
This entry was posted on Monday, July 31st, 2006 at 8:17 am and is filed under Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.